{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:19:50Z","timestamp":1760782790592},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,11,2]],"date-time":"2005-11-02T00:00:00Z","timestamp":1130889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2005,11,22]]},"DOI":"10.1007\/s10549-005-4896-1","type":"journal-article","created":{"date-parts":[[2005,11,2]],"date-time":"2005-11-02T10:54:00Z","timestamp":1130928840000},"page":"205-211","source":"Crossref","is-referenced-by-count":13,"title":["Morphologic and Immunophenotypic Markers as Surrogate Endpoints of Tamoxifen Effect for Prevention of Breast Cancer"],"prefix":"10.1007","volume":"94","author":[{"given":"Syed K.","family":"Mohsin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Craig","family":"Allred","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Kent","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatolio","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary M.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard M.","family":"Elledge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,2]]},"reference":[{"key":"4896_CR1","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","volume":"351","author":"The Early Breast Cancer Trialists' Collaborative Group","year":"1998","unstructured":"Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351 (1998) 1451-1467","journal-title":"Lancet"},{"key":"4896_CR2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"B Fisher, J Costantino, DL Wickerham, C Redmond, MT Kavanah, WM Cronin, V Vogel, A Robidoux, NV Dimitrov, J Atkins, M Daly, S Wieand, E Tan-Chiu, L Ford and N Wolmark, Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90 (1998) 1371-1388","journal-title":"J Natl Cancer Inst"},{"key":"4896_CR3","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1200\/JCO.2001.19.22.4224","volume":"19","author":"JA Hage van der","year":"2001","unstructured":"JA Hage van der, C Velde van de, J-P Julien, M Tubiana-Hulin, C Vandervelden and L Duchateau, Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer Trial 10902. J Clin Oncol 19 (2001) 4224-4237","journal-title":"J Clin Oncol"},{"key":"4896_CR4","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","volume":"15","author":"B Fisher","year":"1997","unstructured":"B Fisher, A Brown, E Mamounas, S Wieand, A Robidoux, RG Margolese, AB Cruz Jr., ER Fisher, DL Wickerham, N Wolmark, A DeCillis, JL Hoehn, AW Lees and NV Dimitrov, Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15 (1997) 2483-2493","journal-title":"J Clin Oncol"},{"key":"4896_CR5","doi-asserted-by":"crossref","unstructured":"ATAC, Trialist's Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial. The Lancet 359: 2131\u20132139, 2002","DOI":"10.1016\/S0140-6736(02)09088-8"},{"key":"4896_CR6","unstructured":"Dowsett, M., Smith, I.E., Trialists, I. Greater Ki67 response after 2 weeks neoadjuvant treatment with anastrozole (A) than with tamoxifen (T) or anastrozole plus tamoxifen (C) in the IMPACT trial: a potential predictor of relapse-free survival. Breast Cancer Res Treatment 82: 56, 2003"},{"key":"4896_CR7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","volume":"312","author":"WD DuPont","year":"1985","unstructured":"WD DuPont and DL Page, Risk factors for breast cancer in women with proliferative breast disease. New Engl J Med 312 (1985) 146-151","journal-title":"New Engl J Med"},{"key":"4896_CR8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jama.1992.03480070057030","volume":"267","author":"SJ London","year":"1992","unstructured":"SJ London, JL Connolly, SJ Schnitt and GA Colditz, A prospective study of benign breast disease, the risk of breast cancer. JAMA: The J Am Med Assoc 267 (1992) 941-944","journal-title":"JAMA: The J Am Med Assoc"},{"key":"4896_CR9","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I","volume":"71","author":"WD Dupont","year":"1993","unstructured":"WD Dupont, FF Parl, WH Hartmann, LA Brinton, AC Winfield, JA Worrell, PA Schuyler and WD Plummer, Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71 (1993) 1258-1265","journal-title":"Cancer"},{"key":"4896_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/oxfordjournals.epirev.a036102","volume":"15","author":"MC Pike","year":"1993","unstructured":"MC Pike, DV Spicer, L Dahmoushm and M Press, Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15 (1993) 17-35","journal-title":"Epidemiol Rev"},{"key":"4896_CR11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0960-0760(00)00104-7","volume":"74","author":"BS Katzenellenbogen","year":"2000","unstructured":"BS Katzenellenbogen, I Choi, R Delage-Mourroux, T Ediger, PGV Martini, M Montano, J Sun, K Weis and JA Katzenellenbogen, Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. Steroid Biochem Mol Biol 74 (2000) 279-285","journal-title":"Steroid Biochem Mol Biol"},{"key":"4896_CR12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/A:1009573710675","volume":"5","author":"DC Allred","year":"2000","unstructured":"DC Allred and S Mohsin, Biological features of premalignant disease in the human breast. J Mammary Gland Biol Neoplasia 5 (2000) 351-364","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"4896_CR13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2559.1989.tb01623.x","volume":"15","author":"D Giri","year":"1989","unstructured":"D Giri, S Dundas, J Nottingham and J Underwood, Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study. Histopathology 15 (1989) 575-584","journal-title":"Histopathology"},{"key":"4896_CR14","first-page":"3752","volume":"54","author":"RM Elledge","year":"1994","unstructured":"RM Elledge, GM Clark, SA W Fuqua, Y-Y Yu and DC Allred, p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock Protein 70 in breast cancer. Cancer Res 54 (1994) 3752-3757","journal-title":"Cancer Res"},{"key":"4896_CR15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jama.1992.03480070057030","volume":"267","author":"S London","year":"1992","unstructured":"S London, J Connolly, SJ Schnitt and GA Colditz, A prospective study of benign breast disease, the risk of breast cancer. JAMA: The J Am Med Assoc 267 (1992) 941-944","journal-title":"JAMA: The J Am Med Assoc"},{"key":"4896_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00000658-194502000-00009","volume":"121","author":"FW Foote","year":"1945","unstructured":"FW Foote and FW Stewart, Comparative studies of cancerous versus non-cancerous breasts. Ann Surg 121 (1945) 197","journal-title":"Ann Surg"},{"key":"4896_CR17","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/1097-0142(19871201)60:11<2751::AID-CNCR2820601127>3.0.CO;2-M","volume":"60","author":"SA Bartow","year":"1987","unstructured":"SA Bartow, DR Pathak, WC Black, CR Key and SR Teaf, Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer 60 (1987) 2751-60","journal-title":"Cancer"},{"key":"4896_CR18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jnci\/90.9.697","volume":"90","author":"P O'Connell","year":"1998","unstructured":"P O'Connell, V Pekkel, SA Fuqua, CK Osborne, GM Clark and DC Allred, Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 90 (1998) 697-703","journal-title":"J Natl Cancer Inst"},{"key":"4896_CR19","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/bjc.1991.395","volume":"64","author":"KJ Walker","year":"1991","unstructured":"KJ Walker, JM Price-Thomas, W Candish and RI Nicholson, Influence of the antioestrogen tamoxifen on normal breast tissue. Br J Cancer 64 (1991) 764-768","journal-title":"Br J Cancer"},{"key":"4896_CR20","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1158\/1078-0432.CCR-04-0171","volume":"10","author":"CJ Fabian","year":"2004","unstructured":"CJ Fabian, BF Kimler, J Anderson, OW Tawfik, MS Mayo, WE Burak Jr., JA O'Shaughnessy, KS Albain, DM Hyams, GT Budd, PA Ganz, ER Sauter, SW Beenken, WE Grizzle, JP Fruehauf, DW Arneson, JW Bacus, MD Lagios, KA Johnson and D Browne, Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulator. Clin Cancer Res 10 (2004) 5403-5417","journal-title":"Clin Cancer Res"},{"key":"4896_CR21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1148\/radiology.210.3.r99mr19799","volume":"210","author":"RJ Jackman","year":"1999","unstructured":"RJ Jackman, KW Nowels, J Rodriguez-Soto, F Marzoni, S Finkelstein and MJ Shepard, Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: False-negative and histologic underestimation rates after long-term follow-up. Radiology 210 (1999) 799-805","journal-title":"Radiology"},{"key":"4896_CR22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1524-4741.2003.09103.x","volume":"9","author":"K Dmytrasz","year":"2001","unstructured":"K Dmytrasz, PI Tartter, H Mizrachy, L Chinitz, SR Smith and A Estabrook, The Significance of Atypical Lobular Hyperplasia at Percutaneous Breast Biopsy. The Breast J 9 (2001) 10-12","journal-title":"The Breast J"},{"key":"4896_CR23","first-page":"3105","volume":"8","author":"CJ Fabian","year":"2002","unstructured":"CJ Fabian, BF Kimler, DA Brady, MS Mayo, CH Chang, JA Ferraro, CM Zalles, AL Stanton, S Masood, WE Grizzle, NF Boyd, DW Arneson and KA Johnson, A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers. Clin Cancer Res 8 (2002) 3105-3117","journal-title":"Clin Cancer Res"},{"key":"4896_CR24","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/jnci\/92.15.1217","volume":"92","author":"CJ Fabian","year":"2000","unstructured":"CJ Fabian, BF Kimler, CM Zalles, JR Klemp, S Kamel, S Zeiger and MS Mayo, Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. J Natl Cancer Inst 92 (2000) 1217-1227","journal-title":"J Natl Cancer Inst"},{"key":"4896_CR25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ t Veer van","year":"2002","unstructured":"LJ t Veer van, H Dai, MJ Vijver van de, YD He, AA Hart, M Mao, HL Peterse, K Kooy van der, MJ Marton, AT Witteveen, GJ Schreiber, RM Kerkhoven, C Roberts, PS Linsley, R Bernards and SH Friend, Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536","journal-title":"Nature"},{"key":"4896_CR26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"CM Perou, T Sorlie, MB Eisen, M van de Rijn, SS Jeffrey, CA Rees, JR Pollack, DT Ross, H Johnsen, LA Akslen, O Fluge, A Pergamenschikov, C Williams, SX Zhu, PE Lonning, AL Borresen-Dale, PO Brown and D Botstein, Molecular portraits of human breast tumours. Nature 406 (2000) 747-752","journal-title":"Nature"},{"key":"4896_CR27","first-page":"S-34","volume":"76","author":"L Wilson","year":"2002","unstructured":"L Wilson, A Vlahou, B Gregory, RR Perry, D McGaughey, O Semmes, GL Wright Jr and C Laronga, A blood test for breast cancer detection. Breast Cancer Res Treatment 76 (2002) S-34","journal-title":"Breast Cancer Res Treatment"},{"key":"4896_CR28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cncr.10238","volume":"94","author":"JA O'Shaughnessy","year":"2002","unstructured":"JA O'Shaughnessy, BM Ljung, WC Dooley, J Chang, HM Kuerer, DT Hung, MD Grant, SA Khan, RF Phillips, K Duvall, DM Euhus, BL King, BO Anderson, SL Troyan, J Kim, U Veronesi and M Cazzaniga, Ductal lavage and the clinical management of women at high risk for breast carcinoma: a commentary. Cancer 94 (2002) 292-298","journal-title":"Cancer"},{"key":"4896_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11912-003-0088-5","volume":"5","author":"WC Dooley","year":"2003","unstructured":"WC Dooley, Ductal lavage, nipple aspiration, and ductoscopy for breast cancer diagnosis. Curr Oncol Rep 5 (2003) 63-5","journal-title":"Curr Oncol Rep"},{"key":"4896_CR30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1075-122X.2004.21595.x","volume":"10","author":"WC Dooley","year":"2004","unstructured":"WC Dooley, A Spiegel, C Cox, R Henderson, L Richardson and J Zabora, Ductoscopy: defining its role in the management of breast cancer. Breast J 10 (2004) 271-272","journal-title":"Breast J"},{"key":"4896_CR31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1185\/030079902125000075","volume":"18","author":"K Mokbel","year":"2002","unstructured":"K Mokbel and AE Elkak, The evolving role of mammary ductoscopy. Curr Med Res Opin 18 (2002) 30-32","journal-title":"Curr Med Res Opin"},{"key":"4896_CR32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1075-122X.2004.21488.x","volume":"10","author":"D Yamamoto","year":"2004","unstructured":"D Yamamoto and K Tanaka, A review of mammary ductoscopy in breast cancer. Breast J 10 (2004) 295-297","journal-title":"Breast J"},{"key":"4896_CR33","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/jnci\/59.4.1073","volume":"59","author":"OW Sartorius","year":"1977","unstructured":"OW Sartorius, HS Smith, P Morris, D Benedict and L Friesen, Cytologic Evaluation of Breast Fluid in the detection of breast disease. J Natl Cancer Inst 59 (1977) 1073-1078","journal-title":"J Natl Cancer Inst"},{"key":"4896_CR34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/oxfordjournals.aje.a116266","volume":"135","author":"M Wrensch","year":"1992","unstructured":"M Wrensch, N Petrakis, E King, R Miike, L Mason, K Chew, M Lee, VL Ernster, JF Hilton, R Schweitzer, WH Goodson III and TK Hunt, Breast Cancer Incidence in Women with Abnormal Cytology in Nipple Aspirates of Breast Fluid. Am J Epidemiol 135 (1992) 130-140","journal-title":"Am J Epidemiol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-005-4896-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-005-4896-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-005-4896-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:29:27Z","timestamp":1559233767000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-005-4896-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,2]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,11,22]]}},"alternative-id":["4896"],"URL":"https:\/\/doi.org\/10.1007\/s10549-005-4896-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,2]]}}}